Achille Sclavo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Achille sclavo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Achille Sclavo Today - Breaking & Trending Today

Covid Drug '80 Times More Potent Than Trump's' in Test in Italy


Chiara Albanese and Flavia Rotondi, Bloomberg News
A lab technician tests material inside a fume cabinet during Covid-19 polymerase chain reaction (PCR) test processing at a laboratory in the Dunkeld suburb of Johannesburg, South Africa, on Wednesday, Feb. 10, 2021. Scientists are concerned the South Africa coronavirus strain could be far more widespread in the U.K. than test results show, threatening plans to start lifting lockdown once vaccines have been deployed. Photographer: Waldo Swiegers/Bloomberg
, Bloomberg
(Bloomberg) Tucked in the Tuscan hills around Siena in Italy, a research lab has come up with an antibody treatment for Covid-19 that its developers say will be 80 times more potent than the one given to former U.S. President Donald Trump in his most critical days in hospital last year. ....

Filippo Anelli , Donald Trump , Claudia Sala , Fabrizio Landi , Achille Sclavo , Giancarlo Giorgetti , Regeneron Pharmaceuticals Inc , Glaxosmithkline Plc , Astrazeneca Plc , Economic Development , Eli Lilly Co , European Union , Toscana Life Sciences Foundation , Italy Thursday , Monte Paschi , Siena Spa , Regeneron Pharmaceuticals , Zeneca Plc , Menarini Biotech , Development Minister Giancarlo Giorgetti , பிலிப்போ னெல்லி , டொனால்ட் துருப்பு , கிளாடியா சலா , ஃபேப்ரிஜியோ லேண்டி , கிளாக்சோஸ்மித்க்லைன் ப்ல் , பொருளாதார வளர்ச்சி ,

Covid-19 drug '80 times more potent than Trump's' in test in Italy


(March 6): Tucked in the Tuscan hills around Siena in Italy, a research lab has come up with an antibody treatment for Covid-19 that its developers say will be 80 times more potent than the one given to former U.S. President Donald Trump in his most critical days in hospital last year.
The therapy is derived from the blood of people who’ve recovered from Covid, and relies on 453 different antibodies. It will also be administered as a single shot rather than a drawn-out infusion, which has been the norm for similar drugs. Clinical trials of about 3,000 doses produced so far started in Italy Thursday, and a roll out for general use could be approved as early as this summer. ....

Filippo Anelli , Donald Trump , Claudia Sala , Fabrizio Landi , Achille Sclavo , Giancarlo Giorgetti , Regeneron Pharmaceuticals Inc , Glaxosmithkline Plc , European Union , Astrazeneca Plc , Economic Development , Eli Lilly Co , Toscana Life Sciences Foundation , Italy Thursday , Monte Paschi , Siena Spa , Regeneron Pharmaceuticals , Zeneca Plc , Menarini Biotech , Development Minister Giancarlo Giorgetti , பிலிப்போ னெல்லி , டொனால்ட் துருப்பு , கிளாடியா சலா , ஃபேப்ரிஜியோ லேண்டி , கிளாக்சோஸ்மித்க்லைன் ப்ல் , ஐரோப்பிய தொழிற்சங்கம் ,